Search for a Medicine

  • Medicines
 
 

Showing 61-79 of 59 matching medicines

Product listings were last updated on 18/06/2024
Trade Name Licence Number & Holder Documents
Bortezomib Biotech Pharma 3.5 mg powder for solution for injection
Powder for solution for injection

Compare
PA25233/001/001
Authorised: 26/06/2020
Target Healthcare Limited
SPC PIL
Bortezomib Clonmel 2.5 mg/ml Solution for Injection
Solution for injection

Compare
PA0126/297/001
Authorised: 20/04/2018
Clonmel Healthcare Ltd
SPC PIL
Bortezomib Fresenius Kabi
Powder for solution for injection

Compare
EU/1/19/1397/001
Authorised: 14/11/2019
Fresenius Kabi Deutschland GmbH
SPC PIL IPAR
Bortezomib Hospira
Powder for solution for injection

Compare
EU/1/16/1114/001
Authorised: 22/07/2016
Pfizer Europe MA EEIG
SPC PIL IPAR
Bortezomib medac 3.5 mg powder for solution for injection
Powder for solution for injection

Compare
PA0623/018/001
Authorised: 18/05/2018
medac Gesellschaft für klinische Spezialpräparate mbH
SPC PIL
Bortezomib Mylan 3.5 mg powder for solution for injection
Powder for solution for injection

Compare
PA0577/191/001
Authorised: 17/05/2019
McDermott Laboratories Ltd., T/A Gerard Laboratories
SPC PIL
Bortezomib Rowex 3.5 mg Powder for solution for injection
Powder for solution for injection

Compare
PA0711/288/001
Authorised: 13/04/2018
Rowex Ltd
SPC PIL
Bortezomib SUN
Powder for solution for injection

Compare
EU/1/16/1102/001
Authorised: 22/07/2016
Sun Phamaceutical Industries Europe B.V.
SPC PIL IPAR
Bosentan Zentiva 125 mg film-coated tablets
Film-coated tablet

Compare
PA1701/011/002
Authorised: 23/02/2024
Zentiva k.s.
SPC PIL
Bosentan Zentiva 62.5 mg film-coated tablets
Film-coated tablet

Compare
PA1701/011/001
Authorised: 23/02/2024
Zentiva k.s.
SPC PIL
Bosulif
Film-coated tablet

Compare
EU/1/13/818/001-002

Pfizer Europe MA EEIG
SPC PIL IPAR
Bosulif
Film-coated tablet

Compare
EU/1/13/818/003-004
Authorised: 27/03/2013
Pfizer Europe MA EEIG
SPC PIL IPAR
BOSULIF
Film-coated tablet

Compare
EU/1/13/818/006-007
Authorised: 22/05/2018
Pfizer Europe MA EEIG
SPC PIL IPAR
Bosutinib Clonmel 100 mg film-coated tablets
Film-coated tablet

Compare
PA0126/369/001
Authorised: 19/04/2024
Clonmel Healthcare Ltd
SPC PIL
Bosutinib Clonmel 400 mg film coated tablets
Film-coated tablet

Compare
PA0126/369/002
Authorised: 19/04/2024
Clonmel Healthcare Ltd
SPC PIL
Bosutinib Clonmel 500 mg film-coated tablets
Film-coated tablet

Compare
PA0126/369/003
Authorised: 19/04/2024
Clonmel Healthcare Ltd
SPC PIL
BOTOX 200 Allergan UnitsPowder for solution for injection
Powder for solution for injection

Compare
PA1824/017/003
Authorised: 18/01/2008
AbbVie Limited
SPC PIL IPAR
BOTOX 50 Allergan Units Powder for solution for injection
Powder for solution for injection

Compare
PA1824/017/002
Authorised: 18/01/2008
AbbVie Limited
SPC PIL IPAR
Botox100 Allergan Units Powder for solution for injection
Powder and solvent for solution for injection

Compare
PA1824/017/001
Authorised: 07/01/2000
AbbVie Limited
SPC PIL IPAR